Israel Englander Atai Life Sciences N.V. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATAI
# of Institutions
101Shares Held
14.8MCall Options Held
168KPut Options Held
77.9K-
Morgan Stanley New York, NY3.33MShares$7.56 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$4.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.97 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$2.16 Million0.03% of portfolio
-
Brown University719KShares$1.63 Million0.44% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $377M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...